We are live on ! Find out more
MCM

McKinley Capital Management Portfolio holdings

AUM $571M
1-Year Est. Return 36.44%
This Fund
S&P 500
This Quarter Est. Return
-14.46%
1 Year Est. Return
+36.44%
3 Year Est. Return
+63.3%
5 Year Est. Return
+224.69%
10 Year Est. Return
+867.52%
AUM
$1.23B
AUM Growth
-$342M
Cap. Flow
-$94.9M
Cap. Flow %
-7.7%
Top 10 Hldgs %
27.89%
Holding
311
New
26
Increased
101
Reduced
155
Closed
26

Top Buys

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$37.9M
2
MRK icon
Merck
MRK
+$16M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$15.2M
4
CVS icon
CVS Health
CVS
+$14.1M
5
PG icon
Procter & Gamble
PG
+$12.7M

Top Sells

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$20.1M
2
PTC icon
PTC
PTC
+$19.2M
3
JWN
Nordstrom
JWN
+$17.2M
4
RACE icon
Ferrari
RACE
+$16.6M
5
BAP icon
Credicorp
BAP
+$16.2M

Sector Composition

Rank Sector Weight
1 Financials 21%
2 Healthcare 20.32%
3 Technology 12.67%
4 Industrials 11.71%
5 Consumer Discretionary 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGNX icon
276
Regenxbio
RGNX
$708M
$25K ﹤0.01%
585
-650
-53% -$38.1K
BAX icon
277
Baxter International
BAX
$14.2B
$21K ﹤0.01%
315
-1,010
-76% -$67.8K
KNX icon
278
Knight Transportation
KNX
$11.4B
$21K ﹤0.01%
840
-916
-52% -$28.4K
VIAV icon
279
Viavi Solutions
VIAV
$9.66B
$19K ﹤0.01%
1,865
-2,041
-52% -$22K
SAGE
280
DELISTED
Sage Therapeutics
SAGE
$18K ﹤0.01%
184
-219
-54% -$25.1K
TSEM icon
281
Tower Semiconductor
TSEM
$28.5B
$18K ﹤0.01%
1,226
-1,351
-52% -$22.5K
EGRX
282
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$17K ﹤0.01%
425
-427
-50% -$22K
FOLD
283
DELISTED
Amicus Therapeutics
FOLD
$16K ﹤0.01%
1,706
-1,845
-52% -$20.3K
AXAS
284
DELISTED
Abraxas Petroleum Corp
AXAS
$11K ﹤0.01%
502
-548
-52% -$19.1K
TME icon
285
Tencent Music
TME
$15.6B
$2K ﹤0.01%
+176
New +$2.25K
ALGN icon
286
Align Technology
ALGN
$12.3B
-692
Closed -$270K
AOS icon
287
A.O. Smith
AOS
$8.7B
-3,454
Closed -$184K
AXGN icon
288
Axogen
AXGN
$2.5B
-2,878
Closed -$106K
BLDR icon
289
Builders FirstSource
BLDR
$8.04B
-4,127
Closed -$60K
CGC
290
Canopy Growth
CGC
$410M
-418
Closed -$203K
CORT icon
291
Corcept Therapeutics
CORT
$12B
-5,798
Closed -$81K
CPRI icon
292
Capri Holdings
CPRI
$1.74B
-3,701
Closed -$254K
EA
293
DELISTED
Electronic Arts
EA
-1,893
Closed -$228K
EL icon
294
Estee Lauder
EL
$32B
-11,111
Closed -$1.61M
FTI icon
295
TechnipFMC
FTI
$27.3B
-8,756
Closed -$204K
GS icon
296
Goldman Sachs
GS
$303B
-1,102
Closed -$247K
IBKR icon
297
Interactive Brokers
IBKR
$39.8B
-17,104
Closed -$237K
JAZZ icon
298
Jazz Pharmaceuticals
JAZZ
$16.7B
-1,700
Closed -$286K
JWN
299
DELISTED
Nordstrom
JWN
-287,414
Closed -$17.2M
LNTH icon
300
Lantheus
LNTH
$6.59B
-6,625
Closed -$99K

Similar funds

McKinley Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, McKinley Capital Management held 311 positions worth $1.23B, down 22% from $1.57B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

McKinley Capital Management withdrew a net $94.9M in Q4 2018, closing 26 positions and reducing 155 holdings. Its most notable exit was PTC, an estimated $19.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Technology.

Against the trend, McKinley Capital Management opened a new position in Berkshire Hathaway Class B worth $14.9M.

  • McKinley Capital Management's largest Q4 2018 buy was Berkshire Hathaway Class B: 72,847 shares worth $14.9M.
  • McKinley Capital Management added most to Nutrien in Q4 2018, an estimated $37.9M increase.
  • McKinley Capital Management's biggest Q4 2018 reduction was Icon, cutting an estimated $20.1M.
  • McKinley Capital Management fully exited PTC in Q4 2018, selling an estimated $19.2M.
  • McKinley Capital Management's ten largest holdings make up 28% of its $1.23B portfolio in Q4 2018.
  • McKinley Capital Management opened 26 new positions and closed 26 in Q4 2018.
  • McKinley Capital Management's portfolio value fell 22% quarter-over-quarter to $1.23B.

Based on McKinley Capital Management's 13F filing for Q4 2018, filed 11 Feb 2019.